News & analysis on the clinical development and manufacture of large molecule drugs
Hired and Retired: Jumping on gene therapy
By Ben Hargreaves
- Last updated on
The gene therapy space is a rapidly developing areas in the industry, as a result those with expertise are finding their knowledge is invaluable to companies looking to advance.
A number of appointments in September were focused on gene therapies, from the biotechs, like Passage Bio, to the bigger manufacturers, such as Catalent. This should not be surprising given the burgeoning pipeline of therapies in the regenerative medicine space.